D I G E S T I V E D I S E A S E R E S E A R C H I N S T I T U T E , T E H R A N U N I V E R S I T Y O F M E D I C A L S C I E N C E S , S H A R I A T I H O S P I T A L , N O R T H K A R G A R A V E . , T E H R A N 1 4 1 1 7 - 1 3 1 3 5 , I R A N

P H O N E + 9 8 - 2 1 - 8 8 3 2 6 4 1 2 • F A X + 9 8 - 2 1 - 2 2 2 5 3 6 3 5 • E - M A I L S I A N M @ A M S . A C . I R

S I A V O S H N A S S E R I - M O G H A D D A M

DATE OF PREPARATION May 11 2017

PERSONAL INFORMATION First Name: Siavosh Last Name: Nasseri-Moghaddam

Birth Date: November 9, 1965 Place of birth: Tehran / Iran

Marital Status: married, two children Gender: Male

e-mail: sianasseri@yahoo.com, sianm@ams.ac.ir

EDUCATION Title Place Year

Elementary School: Bahar-Nov School Tehran / Iran

1971-1976 High School: Alborz High school Graduated in 1983 (top student)

Tehran /Iran

1976-1983 Medical School: Shiraz University Among the top 5%

Shiraz / Iran

1983-1990 Residency of Internal Medicine: Shiraz University of medical Sciences

Shiraz / Iran

1990-1993 Board Certification: One of the three top graduates of the Iranian Board of Internal Medicine

Tehran /Iran

1993

Fellowship in Gastroenterology: Tehran University of medical Sciences

Tehran /Iran

1998-2000

Short Courses: Master of Public Health (MPH): 2007-2008, Tehran University of Medical

Sciences. Medical Education (including teaching, evaluation, curriculum

planning, problem based learning) carried out by Professor Raja Bandranyke from New South Wales University-Australia, Professor Ara S. Tekian from Chicago/Illinois-USA, and Professor Ken Cox from New South Wales University-Australia, all WHO consultants to Iran.

Fellowship in Liver transplantation (Thomas E Starzl Institue of transplantation, Pittsburg, USA, UCSD, UCLA, USA), Concise course of cancer epidemiology (NCI, NIH, USA).

Post-doc training in Endoscopic Submucosal Dissection, NIC, Tokyo, Japan.

ACADEMIC CAREERS Associate Professor of Medicine: Tehran University of Medical Sciences,

2006 Assistant Professor of Medicine: Iran University of Medical Sciences,

1993-1996 Assistant Professor of Medicine and Gastroenterology: Tehran University of

Medical Sciences 1996-2006 Director, Gastroenterology clinical ward, Shariati hospital, since 2005. Member of Educational Development Centers: Iran & Tehran

Universities Since 1993 Designing & implementing workshops in “Medical Education”:

Since 1994 Reviewer for the “Iranian Journal of Medical Sciences”: 1997 to the

present time Reviewer for the “Archives of Iranian Medicine”: 1999 to the present

time Reviewer for the “Cochrane Hepato-biliary Group”: 2000 to the

present time Reviewer for the “Journal of Gastroenterology and Hepatology”: 2002

to the present time. Reviewer for the “Govaresh”: from 2003 Member of the editorial board of the “Archives of Iranian Medicine”,

since 2004 Member of the editorial board of the “Middle East Journal of

Digestive Diseases”, since 2011 Member of the editorial board of the “Acta Medica Iranica”, since

2013 Member of the examination committee of the Iranian Boards of:

Undergraduate comprehensive examination, Internal medicine residency entrance examination, and Internal medicine pre-board examination: 1999 to 2001

Member of Digestive Diseases Research Center (Tehran University): 1998 to the present time

Editor, journal of “Tebbe Dakheli” (The Iranian quarterly journal of internal Medicine):1998-2003

Associate Editor, Archives of Iranian Medicine, since 2004 Director: Gastro-esophageal Reflux Disease research group of the DDRC.

Since 2003 Director: Autoimmune liver disease study group of the DDRC. Since 2003 Director: Upper GI malignant disease research center at the Digestive

Disease Research Institute, Tehran University of Medical Sciences, since 2012

Director: Department of Gastroenterology and Hepatology, Shariati Hospital, Tehran University of Medical Sciences (since 2014)

Director: Fundamentals of Clinical Medicine Course, School of Medicine, Tehran University of Medical Sciences (Since 2014)

Principle Investigator: Autoimmune liver disease registry of Iran

HONORS [ Click here and enter information. ]

PATENTS AND PUBLICATIONS Articles:

1. Effects of Intracisternal TRH on Basal Acid Output and Serum Gastrin in Hyperthyroid Rats. Iranian Journal of Medical Sciences 1992; 17: 87-91.

2. Helicobacter Pylori Prevalence in Two Iranian Provinces with High and Low Incidence of Gastric Carcinoma. Archives of Iranian Medicine 2000; 3:6-9.

3. Malekzadeh R, Nasseri-Moghaddam S, et al. Cyclosporine-A Is A Promising Alternative to Corticosteroids in Autoimmune Hepatitis. Dig Dis Sci 2001; 46(6): 1321-1327.

4. Mohammadzadeh M, Nasseri-Moghaddam S, Allameh AA. Measurement of Glutathione S-transferase and its class-π in plasma tissue biopsies obtained after laparoscopy and endoscopy from subjects with esophagus and gastric cancer. Clinical Biochem 2003; 36: 283-288.

5. Nasseri-Moghaddam S, Malekzadeh R, Sotoudeh M, Tavangar M, Azimi

K, Sohrabpour AA, Mostadjabi P, Fathi H, Minapoor M. Lower esophagus in dyspeptic Iranian patients: a prospective study. J Gastroenterol Hepatol. 2003 Mar; 18(3):315-21.

6. Nasseri-Moghaddam S, Sotoudeh M, Malekzadeh R. Gastroesophageal

Reflux Disease: The New Epidemic (Review article). Arch Iranian Med 2003; 6: 127-140.

7. F. Saidi, R. Malekzadeh, M. Sotoudeh, M. H. Derakhshan, M. J. Farahvash, A. Yazdanbod, Sh. Merat,J. Mikaeli, R. Sotoudehmanesh, S. Nasseri-Moghadam, A. Majidpour, S. Arshi, B. Abedi-Ardakani, A. Yoonessi, F. Sadr, A. Sepehr, D. Fleischer, S. Fahimi. Endoscopic esophageal cancer survey in the western part of the Caspian Littoral. Diseases of the Esophagus (2002) 15, 214–218.

8. Shahin Merat, Reza Malekzadeh, Masoud Reza Sohrabi, Masoud Sotoudeh, Nasser Rakhshani, Amir Ali Sohrabpour, Siavosh Naserimoghadam. Probucol in the treatment of non-alcoholic steatohepatitis: A double blind randomized controlled study. Journal of Hepatology 38 (2003) 414–418.

9. Shahin Merat, Reza Malekzadeh, Masoud Reza Sohrabi,Mahshid Hormazdi, Siavosh Naserimoghadam, Javad Mikaeli., Mohammad Jafar Farahvash, Reza Ansari, Rasoul Sotoudehmanesh, Morteza Khatibian. Probucol in the treatment of non-alcoholic steatohepatitis: An open label study. J Clin Gastroenterol 2003;36(3):266–268.

10. Abbas Yazdanbod MD, Siavosh Nasseri-Moghaddam, Reza Malekzadeh. Upper Gastro-intestinal Cancer in Ardabil, North-west of Iran. Arch Iranian Medicine 2004;7: 173-177.

11. Reza Malekzadeh, Mehdi Mohamadnejad, Siavosh Nasseri-Moghaddam, Nasser Rakhshani, Seyed Mohamad Tavangar, Amir Ali Sohrabpour, Soosan Tahaghoghi. Reversibility of Cirrhosis in Autoimmune Hepatitis. American Journal of Medicine 2004; 117: 125-129. Times Cited: 4

12. F Islami, F Kamangar, K Aghcheli, S Fahimi, S Semnani, N Taghavi, HA Marjani, S Merat, S Nasseri-Moghaddam, A Pourshams, M Nouraie, M Khatibian, B Abedi, MH Brazandeh, R Ghaziani, M Sotoudeh, SM Dawsey, CC Abnet, PR Taylor, R Malekzadeh. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. British Journal of Cancer 2004; 1-5. Times Cited: 9

13. Shahbazkhani B, Mohamadnejad M, Malekzadeh R, Akbari MR, Esfahani MM, Nasseri-Moghaddam S, Sotoudeh M, Elahyfar A. Coeliac disease is the most common cause of chronic diarrhoea in Iran. Eur J Gastroenterol

Hepatol. 2004 Jul;16(7):665-8. Times Cited: 4

14. Malekzadeh R, Mohamadnejad M, Rakhshani N, Nasseri-Moghaddam S, Merat S, Tavangar SM, Sohrabpour AA Reversibility of cirrhosis in chronic hepatitis B. Clin Gastroenterol Hepatol. 2004 Apr; 2(4):344-7.

15. Malekzadeh R, Merat S, Derakhshan MH, Siavoshi F, Yazdanbod A, Mikaeli J, Sotoudemanesh R, Sotoudeh M, Farahvash MJ, Nasseri-Moghaddam S, Pourshams A, Dolatshahi S, Abedi B, Babaei M, Arshi S, Majidpour A. Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population. J Gastroenterol Hepatol. 2003 Jan;18(1):13-7.

16. Shahbazkhani B, Forootan M, Merat S, Akbari MR, Nasserimoghadam S, Vahedi H, Malekzadeh R. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther. 2003 Jul 15;18(2):231-5.

17. Nasseri-Moghaddam S. Commented Summary: Does a Surgical Anti-Reflux Procedure Decrease the Incidence of Esophageal Adenocarcinoma in Barrett’s Esophagus? A Meta-Analysis. Archives of Iranian Medicine 2004; 7: 76-78.

18. Nasseri-Moghaddam S, Malekzadeh R. Commented Summary: Screening for Hepatitis C Virus Infection: A Review of the Evidence for the US Preventive Services Task Force. Archives of Iranian Medicine 2004; 7: 167-168.

19. Zendehdel N, Nasseri-Moghaddam S, Malekzadeh R, Massarrat S, Sotoudeh M, Siavoshi F. Hekicobacter Pylori Reinfection Rate Three Years after Successful Eradication. J Gastroenterol Hepatol. 2005, 20 (3): 401-4.

20. Mohamadnejad M, Malekzadeh R, Nasseri-Moghaddam S, Hagh-Azali S, Rakhshani N, Tavangar SM, Sedaghat M, Alimohamadi SM. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis. Dig Dis Sci. 2005 Mar; 50(3):547-51.

21. Nasseri-Moghaddam S, Abrishami A, Malekzadeh R. Percutaneous needle aspiration, injection, and reaspiration with or without benzimidazole coverage for uncomplicated hepatic hydatid cysts. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003623. Review.

22. Nasseri-Moghaddam S, Malekzadeh R. "Systematic review": is it different from the "traditional review"? Arch Iran Med. 2006 Jul; 9(3):196-9. Review

23. Nasseri-Moghaddam S. Thyroxine in goiter Helicobacter pylori infection,

and chronic gastritis. Arch Iran Med. 2006 Jul; 9(3):302-3.

24. Rasmi Y, Allameh A, Nasseri-Moghaddam S, Gill P, Moghaddam MF, Hedayati M. Comparison of glutathione S-transferase-Pi expression at mRNA levels in oesophageal mucosa using RT-PCR-ELISA in individuals with reflux diseases, adenocarcinoma and squamous cell carcinoma. Clin Biochem. 2006 Oct; 39(10):997-1001.

25. Nasseri-Moghaddam S, Malekzadeh R. Esophageal and cardia cancers summit: report of the first meeting. Arch Iran Med. 2006 Oct; 9(4):442-9.

26. Somi MH, Farhang S, Mirinezhad K, Jazayeri E, Nasseri-Moghaddam S, Moayeri S, Yasrebinia S. Prevalence and precipitating factors of gastroesophageal reflux disease in a young population of Tabriz, Northwest of Iran. Saudi Med J. 2006 Dec;27(12):1878-81.

27. Nasseri-Moghaddam S, Razjouyan H, Nouraie M, Alimohammadi M, Mamarabadi M, Vahedi H, Pourshams A, Mohamadnejad M, Zamani F, Sadr F, Darvish-Moghaddam S, Farsi P, Malekzadeh R. Inter- and intra-observer variability of the Los Angeles classification: a reassessment. Arch Iran Med. 2007 Jan; 10(1):48-53.

28. Khatibian M, Ajvadi Y, Nasseri-Moghaddam S, Ebrahimi-Dariani N, Vahedi H, Zendehdel N, Sotoudehmanesh R, Agah S, Mikaeli J, Pourshams A, Ali-Asgari A, Malekzadeh R, Massarrat S. Furazolidone-Based, Metronidazole-Based, or a Combination Regimen for Eradication of Helicobacter pylori in Peptic Ulcer Disease. Arch Iran Med. 2007 Apr; 10(2):161-7.

29. Nouraie M, Radmard AR, Zaer-Rezaii H, Razjouyan H, Nasseri-Moghaddam S, Malekzadeh R. Hygiene Could Affect GERD Prevalence Independently: A Population-Based Study in Tehran. Am J Gastroenterol. 2007 Jul; 102(7):1353-60.

30. Nouraie M, Razjouyan H, Assady M, Malekzadeh R, Nasseri-Moghaddam S. Epidemiology of Gastroesophageal Reflux Symptoms in Tehran, Iran: A Population-Based Telephone Survey. Arch Iran Med. 2007 Jul; 10(3):289-294.

31. Nasseri-Moghaddam S, Mofid A, Nouraie M, Abedi B, Pourshams A, Malekzadeh R, Sotoudeh M. The Normal Range of Duodenal Intraepithelial Lymphocytes. Arch Iranian Med 2008; 11 (2): 136 – 142.

32. Nasseri-Moghaddam S, Razjouyan H, Ali-Mohammadi SM,

Mamarabadi M, Ghotbi MH, Mostajabi P, Sohrabpour AA, Sotoudeh M, Abedi B, Mofid A, Nouraie M, Tofangchiha S, Malekzadeh R. BMC Gastroenterology 2007, 7:42 doi:10.1186/1471-230X-7-42.

33. Nasseri-Moghaddam S, Mofid A, Ghotbi MH, Razjouyan H, Nouraie M, Radmard AR, Zaer-Rezaie, H, Habibi R, Rafat-Zand K, Malekzadeh R. Epidemiological Study of Gastro-Esophageal Reflux Disease: Reflux in Spouse as A Risk Factor. Aliment Pharmacol Ther; 2008 (28): 144–153.

34. Malekzadeh R, Nasseri-Moghaddam S. Reducing Gastric Cancer Mortality in Developing Countries: Learning from the Experience in Japan. Arch Iran Med. 2008 Sep;11(5):588-90.

35. Malekzadeh F, Alberti C, Nouraei M, Vahedi H, Zaccaria I, Meinzer U, Nasseri-Moghaddam S, Sotoudehmanesh R, Momenzadeh S, Khaleghnejad R, Rashtak S, Olfati G, Malekzadeh R, Hugot JP. Crohn’s Disease and Early Exposure to Domestic Refrigeration. PLoS One. 2009; 4(1): e4288. Epub 2009 Jan 29.

36. Nasseri-Moghaddam S. Tea Drinking Habits and Esophageal cancer in High Risk Area. Arch Iran Med. 2009 May;12(3):330-2.

37. Nasseri-Moghaddam S. Letter to the editor. Arch Iranian Med 2009; 12 (4): 437 – 438.

38. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, Merat S, Nasseri-Moghaddam S, Semnani S, Sepehr A, Wakefield J, Møller H, Abnet CC, Dawsey SM, Boffetta P, Malekzadeh R. Socio-economic Status and Esophageal Cancer: Results from a Population-Based Case-Control Study in a High-Risk Area. Int J Epidemiol. 2009 May 4. [Epub ahead of print].

39. Vahedi H, Momtahen S, Olfati G, Abtahi A, Hosseini S, Kazzazi AS, Khademi H, Rashtak S, Khaleghnejad R, Tabrizian T, Hamidi Z, Nouraie M, Malekzadeh F, Merat S, Nasseri-Moghaddam S, Sotoudehmanesh R, Larijani B. A Case-Control Study on Risk factors of Osteoporosis in Patients with Crohn’s Disease. Arch Iran Med 2009; 12 (6): 570 – 575.

40. Vahedi H, Merat S, Momtahen S, Olfati G, Kazzazi AS, Tabrizian T, Rashtak S, Khaleghnejad R, Khademi H, Malekzadeh F, Nasseri-Moghaddam S, Malekzadeh R. Epidemiologic

Characteristics of 500 Patients with Inflammatory Bowel Disease in Iran Studied from 2004 to 2007. hjArch Iranian Med 2009; 12 (5): 454 – 460.

41. Allameh AA, Rasmi Y, Nasseri-Moghaddam S, Tavangar SM, Sharifi R, Sadreddini M. Immunohistochemical Analysis of Selected Molecular Markers in Esophagus, Precancerous, Adenocarcinoma and Squamous Cell Carcinoma in Iranian Subjects. Cancer Epidemiology 33 (2009) 79–84.

42. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost AA, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis. Vaccine 28 (2010) 623–631.

43. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost AA, Ghalichi L, Fotouhi A. Seroprotection of Hepatitis B Vaccine and Need for Booster Dose: A Meta-Analysis. Hepatitis Monthly 2009; 9(4): 293-304.

44. Yarandi SS, Nasseri-Moghaddam S, Mostajabi P, Malekzadeh R. Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms. J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):41-5.

45. Sohrabi S, Nouraie M, Khademi H, Baghizadeh S, Nasseri-Moghaddam S, Malekzadeh R. Epidemiology of uninvestigated gastrointestinal symptoms in adolescents: a population-based study applying the Rome II questionnaire. World J Gastroenterol. 2010 Mar 14;16(10):1232-8.

46. Poorolajal J, Haghdoost AA, Mahmoodi M, Majdzadeh R, Nasseri-

Moghaddam S, Fotouhi A. Capture-recapture method for assessing

publication bias. J Res Med Sci 2010;15:107-15.

47. Nasseri-Moghaddam S, Abrishami A, Taefi A, Malekzadeh R.

Percutaneous needle aspiration, injection, and re-aspiration with or

without benzimidazole coverage for uncomplicated hepatic hydatid cysts.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD003623.

48. Poorolajal J, Mahmoodi M, Haghdoost A, Majdzadeh R, Nasseri-

Moghaddam S, Ghalichi L, Fotouhi A. Booster dose vaccination for

preventing hepatitis B. Cochrane Database Syst Rev. 2010 Nov

10;(11):CD008256.

49. Nasseri-Moghaddam S, Nokhbeh-Zaeem H, Saniee P, Pedramnia S,

Sotoudeh M, Malekzadeh R. Oral Nitrate Reductase Activity and Erosive

Gastro-esophageal Reflux Disease: A Nitrate Hypothesis for GERD

Pathogenesis. Dig Dis Sci. 2012 Feb;57(2):413-8. Dig Dis Sci. 2011 Sep 1.

[Epub ahead of print].

50. Azizi MH, Nasseri-Moghaddam S. Impact of quality mentorship on

achievement of Shiraz Medical School in the 1970s and the Role of

Professor Faramarz Ismail-Beigi. Arch Iranian Med 2012; 15(4): 259-262.

51. Nasseri-Moghaddam S, Mofid A, Razjouyan H. Dietary Nitrate may have

a role in development of Gastro-Esophageal Reflux Disease. Arch Iran Med.

2011 Sep;14(5):312-4.

52. Nasseri-Moghaddam S. Editorial: Sensing the blowing winds of change.

Middle East Journal of Digestive Diseases 2010; 2: 63-65.

53. Bagheri M, Ashrafi M, Mohamadnejad M, Abdollahzadeh-Hosseini L,

Nasseri-Moghaddam S, Merat S, Saberi-Firouzi M, Sotoudeh M,

Malekzadeh R. Eosinophilic gastroenteritis: A case series from Iran. Middle

East Journal of Digestive Diseases 2011; 3: 115-118.

54. Nasseri-Moghaddam S. Topography of gastritis and its severity in 864 first

degree relatives of gastric cancer patients (Letter to the editor). Arch Iran

Med 2011; 14(5): 366.

55. Khademi H, Radmard AR, Malekzadeh F, Kamangar F, Nasseri-

Moghaddam S, Johansson M, Byrnes G, Brennan P, Malekzadeh R.

Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in

patients for upper GI malignancy in patients with dyspepsia in a GI clinic: A

7-year cross-sectional study. PLoS ONE 7(6): e39173. Doi:

101271/journal.pone.0039173.

56. Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S,

Abaie B, Islami F, Nasseri-Moghaddam S, Etemadi A, Byrnes G, Abnet

CC, Dawsey SM, Day NE, Pharaoh PD, Boffetta P, Brennan P, Kamangar

F. Opium Use in Golestan Cohort Study: Prospective Cohort Study of

50,000 Adults in Iran. BMJ 2012;344:e2502 doi: 10.1136/bmj.e2502

(Published 17 April 2012).

57. Malekzadeh Z, Haghazali S, Sepanlou SG, Vahedi H, Merat S, Sotoudeh M,

Nasseri-Moghaddam S, Malekzadeh R. Clinical features and long term

outcome of 102 treated autoimmune hepatitis patients. Hepat Mon 2012

Feb;12(2):92-9. doi: 10.5812/hepatmon.808. Epub 2012 Feb 29.

58. Nasseri-Moghaddam S. Inflammatory bowel disease. Middle East Journal

of Digestive Diseases 2012;4(2):77-89.

59. Amirimani B, Nikfam S, Albaji M, Vahedi S, Nasseri-Moghaddam S,

Sharafkhah M, Ansari R, Vahedi H. Probiotics vs. Placebo in Irritable Bowel

Syndrome: A Randomized Controlled Trial. Middle East Journal of

Digestive Diseases 2013;5(2): 98-102.

60. Role of Th1/Th2 cells and related cytokines in autoimmune hepatitis.

Behfarjam F, Sanati MH, Nasseri Moghaddam S, Ataei M, Nikfam S,

Jadali Z. Turk J Gastroenterol. 2017 Mar;28(2):110-114. 2017.17501. Epub

2017 Jan 25.

61. Medical Journal Club as a New Method of Education:

Modifications for Improvement. Sadeghi A, Biglari M, Nasseri-

Moghaddam S, Soltani A. Arch Iran Med. 2016 Aug;19(8):556-60

62. Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income

Country: A Nation-wide Study from Iran. Malekzadeh MM, Vahedi H,

Gohari K, Mehdipour P, Sepanlou SG, Ebrahimi Daryani N, Zali MR,

Mansour-Ghanaei F, Safaripour A, Aghazadeh R, Vossoughinia H, Fakheri

H, Somi MH, Maleki I, Hoseini V, Ghadir MR, Daghaghzadeh H, Adibi P,

Tavakoli H, Taghavi A, Zahedi MJ, Amiriani T, Tabib M, Alipour Z,

Nobakht H, Yazdanbod A, Sadreddini M, Bakhshipour A, Khosravi A,

Khosravi P, Nasseri-Moghaddam S, Merat S, Sotoudehmanesh R,

Barazandeh F, Arab P, Baniasadi N, Pournaghi SJ, Parsaeian M, Farzadfar F,

Malekzadeh R. Arch Iran Med. 2016 Jan;19(1):2-15.

63. Mean Polyp per Patient Is an Accurate and Readily Obtainable Surrogate for

Adenoma Detection Rate: Results from an Opportunistic Screening

Colonoscopy Program. Delavari A, Salimzadeh H, Bishehsari F, Sobh

Rakhshankhah E, Delavari F, Moossavi S, Khosravi P, Nasseri-

Moghaddam S, Merat S, Ansari R, Vahedi H, Shahbazkhani B,

Saberifiroozi M, Sotoudeh M, Malekzadeh R. Middle East J Dig Dis. 2015

Oct;7(4):214-9.

64. Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.

Moossavi S, Bishehsari F, Ansari R, Vahedi H, Nasseri-Moghaddam S,

Merat S, Sobhani I, Keshavarzian A, Malekzadeh R. Middle East J Dig Dis.

2015 Jul;7:177-80.

65. Variations of gastric corpus microbiota are associated with early esophageal

squamous cell carcinoma and squamous dysplasia. Nasrollahzadeh D,

Malekzadeh R, Ploner A, Shakeri R, Sotoudeh M, Fahimi S, Nasseri-

Moghaddam S, Kamangar F, Abnet CC, Winckler B, Islami F, Boffetta P,

Brennan P, Dawsey SM, Ye W. Sci Rep. 2015 Mar 6;5:8820.

66. Adenoma detection rates in an opportunistic screening colonoscopy

program in Iran, a country with rising colorectal cancer incidence. Delavari

A, Bishehsari F, Salimzadeh H, Khosravi P, Delavari F, Nasseri-

Moghaddam S, Merat S, Ansari R, Vahedi H, Shahbazkhani B,

Saberifiroozi M, Sotoudeh M, Malekzadeh R. BMC Gastroenterol. 2014

Nov 18;14:196.

67. Characteristics of colorectal polyps and cancer; a retrospective review of

colonoscopy data in iran. Delavari A, Mardan F, Salimzadeh H, Bishehsari F,

Khosravi P, Khanehzad M, Nasseri-Moghaddam S, Merat S, Ansari R,

Vahedi H, Shahbazkhani B, Saberifiroozi M, Sotoudeh M, Malekzadeh R.

Middle East J Dig Dis. 2014 Jul;6(3):144-50.

68. Gastroesophageal Reflux Disease and overall and Cause-specific Mortality:

A Prospective Study of 50000 Individuals. Islami F, Pourshams A, Nasseri-

Moghaddam S, Khademi H, Poutschi H, Khoshnia M, Norouzi A,

Amiriani T, Sohrabpour AA, Aliasgari A, Jafari E, Semnani S, Abnet CC,

Pharaoh PD, Brennan P, Kamangar F, Dawsey SM, Boffetta P, Malekzadeh

R. Middle East J Dig Dis. 2014 Apr;6(2):65-80.

69. Oral Nitrate Reductase Activity Is Not Associated with Development of

Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic

Steatohepatitis (NASH): A Pilot Study. Barzin G, Merat S, Nokhbeh-Zaeem

H, Saniee P, Pedramnia S, Mostashfi Habibabadi A, Nasseri-Moghaddam

S. Middle East J Dig Dis. 2014 Jan;6(1):23-7.

70. Serum cystatin-C is not superior to serum creatinine in predicting glomerular

filtration rate in cirrhotic patients. Nasseri-Moghaddam S, Ganji MR,

Kochari MR, Tofangchiha S. Middle East J Dig Dis. 2013 Oct;5(4):209-16.

71. Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-

immune Hepatitis: Interim Analysis Report of a Randomized Controlled

Trial. Nasseri-Moghaddam S, Nikfam S, Karimian S, Khashayar P,

Malekzadeh R. Middle East J Dig Dis. 2013 Oct;5(4):193-200.

72. Probiotic vs. Placebo in Irritable Bowel Syndrome:A Randomized

Controlled Trial. Amirimani B, Nikfam S, Albaji M, Vahedi S, Nasseri-

Moghaddam S, Sharafkhah M, Ansari R, Vahedi H. Middle East J Dig Dis.

2013 Apr;5(2):98-102.

73. Determinants of gastroesophageal reflux disease, including hookah smoking

and opium use- a cross-sectional analysis of 50,000 individuals. Islami F,

Nasseri-Moghaddam S, Pourshams A, Poustchi H, Semnani S, Kamangar

F, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P,

Abnet CC, Boffetta P, Malekzadeh R. PLoS One. 2014 Feb 21;9(2):e89256.

74. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H.

Cochrane Database Syst Rev. 2013 Dec 27;(12).

75. Meta-analyses: does long-term PPI use increase the risk of gastric

premalignant lesions? Eslami L, Nasseri-Moghaddam S. Arch Iran Med.

2013 Aug;16(8):449-58.

76. Surgical resection versus liver transplant for patients with hepatocellular

carcinoma. Taefi A, Abrishami A, Nasseri-Moghaddam S, Eghtesad B,

Sherman M. Cochrane Database Syst Rev. 2013 Jun 29;(6):CD006935.

77. Treatment of gastro-esophageal reflux disease may improve surgical

outcomes for chronic otitis media. Karimi Yazdi A, Tajdini A, Malekzadeh

R, Nasseri-Moghaddam S, Mazlum M, Nokhbeh-Zaeem H, Biazar P,

Amiri M. Middle East J Dig Dis. 2012 Oct;4(4):224-7.

78. Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in

patients with dyspepsia in a GI clinic: a 7-year cross-sectional study.

Khademi H, Radmard AR, Malekzadeh F, Kamangar F, Nasseri-

Moghaddam S, Johansson M, Byrnes G, Brennan P, Malekzadeh R. PLoS

One. 2012;7(6):e39173.

79. Opium use and mortality in Golestan Cohort Study: prospective cohort

study of 50,000 adults in Iran. Khademi H, Malekzadeh R, Pourshams A,

Jafari E, Salahi R, Semnani S, Abaie B, Islami F, Nasseri-Moghaddam S,

Etemadi A, Byrnes G, Abnet CC, Dawsey SM, Day NE, Pharoah PD,

Boffetta P, Brennan P, Kamangar F. BMJ. 2012 Apr 17;344.

80.

Case reports: 1. Nasseri-Moghaddam S, Mohamadnejad M, Malekzadeh R, Tavangar

SM. Gastrointestinal: Polypoid arteriovenous malformation of the colon. J Gastroenterol Hepatol 2004; 19: 1419.

2. Hosseini V, Nasseri-Moghaddam S, Soroosh AR, Hakimian MR. Photoclinic: Ileal duplication cyst. Arch Iran Med. 2007 Jul;10(3):417-9.

3. Nasseri-Moghaddam S, Nokhbeh-Zaeem H, Soroush Z, Bani-Solaiman Sheybani S, Mazloum M. Ectopic location of the ampulla of Vater within the pyloric channel. Middle East Journal of Digestive Diseases 2011; 3: 56-58.

4. Niknam R, Mahmoudi L, Nasseri-Moghaddam S. An incidentally swallowed toothbrush. Arch Iran Med. 2012 Mar;15(3):177-8. doi: 012153/AIM.0015.

Abstracts: 1. Aortic Size in Mitral Valve Prolapse: Oral presentation in the 4th

International Congress of Internal Medicine 1993, Tehran / Iran. 2. Effect of H-2 Blockers on Calcium Metabolism in Patients with Secondary

Hyperparathyroidism: Oral presentation in the 2nd International Congress of Endocrinology 1993, Tehran / Iran

3. Duodenal Ulcer Rebleeding is Associated with Persistent Helicobacter Pylori Infection. Gastroenterology; April 1997: 208.

4. Helicobacter Pylori Prevalence in Two Iranian Provinces with High and Low Incidence of Gastric Carcinoma. Digestion; August 1998.

5. Should IBS Patients be Screened for Celiac Disease Gastroenterology April 1999; 116(4): G3946

6. Role of Celiac Disease among Iranian Patients with Chronic Diarrhea. Presented in the 12th International Congress of Geographic Medicine, Nov. 1999, Shiraz / Iran.

7. Microemulsion Formulation of Cyclosporine-A in Autoimmune Hepatitis. Gastroenterology April 1999; 116(4): L0275.

8. Prevalence of Endoscopic GERD in Dyspeptic Patients Undergoing Upper GI Endoscopy (interim report). Presented in the 10th Iranian Congress of Internal Medicine, May 1999, Tehran / Iran.

9. Appropriateness of Hospital Admissions and In-hospital Stay in a University Hospital in Tehran. Presented in the 10th Iranian Congress of Internal Medicine, May 1999, Tehran / Iran.

10. Ursodeoxyxholic Acid for NASH: A Prospective Randomized Controlled Study. Presented orally at the distinguished plenary session at DDW 2002, SanFrancisco.

11. Epidemiology of constipation in Tehran, Iran. Nouraie M, Razjouyan H, Asadi M, Nasseri-Moghaddam S. Govaresh, December 2005; 10 (Supplement):35-35.

12. Is Response to Medical Therapy Different between Patients with Erosive and Non-erosive Reflux Disease? Interim Report of the Iranian GERD Cohort. Alimohammadi M, Mamarabadi M, Razjouyan H, Nouraei M, Ghotbi MH, Tofangchiha S, Safavi M, Malekzadeh R, Didar L, Khalili SH, Nasseri-Moghaddam S. Govaresh, December 2005; 10 (Supplement): 45-45.

13. The Iranian GERD Study: Preliminary Report. Alimohammadi M, Mofid A, Razjouyan H, Mamarabadi M, Nouraie M, Ghotbi MH, Tofangchiha S, Malekzadeh R, Nasseri-Moghaddam S. Govaresh, December 2005;10 (Supplement):46-46

14. Efficiency of H&E staining in detecting H.Pylori density in gastric samples. Alimohammadi M, Razjouyan H, Mamarabadi M, Ghotbi MH, Abedi B, Sotoudeh M, Malekzadeh R, Nasseri-Moghaddam S. Govaresh, December 2005;10 (Supplement): 52-52

15. What is the role of Helicobacter Pylori in induction of intestinal metaplasia in GERD patients? The PARSI database. Govaresh November 2006; 11 (Supplement): 33-3

16. Risk Factors for Gastro-esophageal Reflux Disease: Results of a Population-Based Study. Govaresh November 2006; 11 (Supplement): 31-31.

17. Validation of the Quality of Life In Reflux and Dyspepsia (QOLRAD) Questionnaire in Iranian patients with GERD. Govaresh November 2006; 11 (Supplement): 28-28.

18. Prevalence of Irritable Bowel Syndrome (IBS) in patients with Gastro esophageal reflux disease (GERD). Govaresh November 2006; 11 (Supplement):32-32.

19. Nasseri-Moghaddam S, Malekzadeh R, Razjouyan H, Nouraie M, Mamarabadi M, Alimohammadi M, Vahedi H, Pourshams A, Mohamadnejad M, Zamani F, Sadr F, Darvish-Moghaddam S, Farsi P. abstract presented orally at the Digestive Disease Week, Chicago, IL, USA, May 2005.

20. Nouraie M, Razjouyan H, Assady M, Nasseri-Moghaddam S. Gastroesophageal reflux disease in Tehran, Iran. Gastroenterology 130 (4): A170-A170 Suppl. 2 APR 2006

21. Nasseri-Moghaddam S, Razjouyan H, Nouraie SM, et al. Netgerd or Helicobacter pylori: Which is responsible for carditis?; The parsi database . GASTROENTEROLOGY 132 (4): A279-A279 Suppl. 2 APR 2007.

22. Nouraie SM, Zaer-Rezaii H, Radmard AR, et al. GERD overlaps other gastrointestinal symptoms; Results of a population based study. GASTROENTEROLOGY 132 (4): A407-A408 Suppl. 2 APR 2007.

23. Nouraie SM, Sohrabi S, Baghizadeh S, et al. Functional GI disorders (FGID) in adolescent, epidemiology and reliability of the Rome II questionnaire in Iran . GASTROENTEROLOGY 132 (4): A409-A409 Suppl. 2 APR 2007

24. Nasseri-Moghaddam S, Rajouyan H, Mamarabadi M, et al. Clinical, demographic, and habit characteristics of GERD patients with and without erosive esophagitis GASTROENTEROLOGY 132 (4): A410-A410 Suppl. 2 APR 2007

25. Ajvadi Y, Malekzadeh R, Nasseri-Moghaddam S, et al. Effect of 2 weeks furazolidone- or 2 weeks metronidazole- or combination of, 1week furazolidone+1 week metronidazole-based anti Helicobacter pylori regimens in peptic ulcer: A randomized-controlled multicenter trial. GASTROENTEROLOGY 130 (4): A93-A93 Suppl. 2 APR 2006

26. Nouraie M, Asadi M, Razjouyan H, et al. Gastroesophageal reflux disease in Tehran. GASTROENTEROLOGY 130 (4): A170-A170 Suppl. 2 APR 2006

27. Nasseri-Moghaddam S, Malekzadeh R, Karimian S Cyclosporine-a versus prednisolone for induction of remission in patients with autoimmune hepatitis: Interim report of a randomized controlled trial . GASTROENTEROLOGY 130 (4): A281-A281 Suppl. 2 APR 2006

28. Nasseri-Moghaddam S, Razjouyan H, Nouraie M, et al. Inter- and intra-

observer variability of the LosAngeles classification for GERD: Preliminary report . GASTROENTEROLOGY 128 (4): A91-A91 Suppl. 2 APR 2005

29. Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S, et al. Impact of treatment on liver fibrosis in autoimmune hepatitis and chronic hepatitis B GASTROENTEROLOGY 124 (4): A382-A382 Suppl. S APR 2003

30. Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S, et al. Reversibility of cirrhosis in autoimmune hepatitis . GASTROENTEROLOGY 124 (4): A385-A385 Suppl. S APR 2003

Books: 1. Review on “Inteferons” published in the form of a booklet for use of house-

officers and attending staff in the division of Gastroenterology.

2. Siavosh Nasseri-Moghaddam, Reza Malekzadeh. Esophageal and Cardia Cancers: Report of the First Summit. 1th ed. Place: Center for International Collaboration and Research (ISMO), Tehran, Iran; 2006: 52 pages.

3. Nasseri-Moghaddam S. Percutaneous Needle Aspiration, Injection and Re-aspiration Technique for Liver Hydatid Cysts. In: Filipou DK (eds), Advances in Hydatid Disease Diagnosis and Treatment. Broken Hill Publishers Ltd, 2013, Nicosia, Cyprus.

PROFESSIONAL EXPERIENCE May 2002-June 2002, Thomas Starzl Institute of Transplantation, Pittspurg, USA,

visiting scientist for liver transplantation June 2002-July 2002, National Cancer Institute, National Institutes of Health,

Bethesda, MD, USA, visiting scientist and participant in the summer course on cancer epidemiology

July 2002-August 2002, UCLA transplant center, Los Angeles, CA, USA, visiting scientist for liver transplantation

August 2002-September 2002, UCSD transplant center, San Diego, CA, USA, visiting scientist for liver transplantation

September 2002-November 2002, Yale Medical Center, Yale University, New Haven, CT, USA, visiting scientist for advanced endoscopic techniques including endoscopic ultrasonography

Member of the editorial board: Archives of Iranian Medicine, since 2004 Member of the editorial board: Middle East Journal of Digestive Diseases, Since

2009

PROFESSIONAL MEMBERSHIPS Member, Iranian Medical Council (IMC)

Member, Iranian Association of Gastroenterology and Hepatology (IAGH), serving as vice-president of IAGH since 2010

Member, American Gastroenterological Association (AGA)

Member, American Association for Study of Liver Disease (AASLD)

Member, American Society of Gastro-intestinal Endoscopy (ASGE)

LANGUAGES Fluent in written and spoken Farsi

Fluent in written and spoken English

Beginner in French